Modeling vaccination strategies with limited early COVID-19 vaccine access in low- and middle-income countries: A case study of Thailand

被引:9
作者
Anupong, Suparinthon [1 ,2 ]
Chantanasaro, Tanakorn [1 ,2 ]
Wilasang, Chaiwat [1 ,2 ]
Jitsuk, Natcha C. [1 ,2 ]
Sararat, Chayanin [1 ,2 ]
Sornbundit, Kan [2 ,3 ]
Pattanasiri, Busara [2 ,4 ]
Wannigama, Dhammika Leshan [5 ,6 ,7 ,8 ,9 ,10 ]
Amarasiri, Mohan [11 ]
Chadsuthi, Sudarat [2 ,12 ]
Modchang, Charin [1 ,2 ,13 ,14 ]
机构
[1] Mahidol Univ, Fac Sci, Dept Phys, Biophys Grp, Bangkok 10400, Thailand
[2] Mahidol Univ, Fac Sci, Ctr Dis Modeling, Bangkok 10400, Thailand
[3] King Mongkuts Univ Technol Thonburi, Ratchaburi Learning Pk, Ratchaburi, Thailand
[4] Kasetsart Univ Kamphaeng Saen Campus, Fac Liberal Arts & Sci, Dept Phys, Nakhon Pathom 73140, Thailand
[5] Yamagata Prefectural Cent Hosp, Dept Infect Dis & Infect Control, Yamagata, Japan
[6] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Dept Microbiol,Fac Med, Bangkok, Thailand
[7] Chulalongkorn Univ, Fac Med, Ctr Excellence Antimicrobial Resistance & Stewards, Bangkok, Thailand
[8] Univ Western Australia, Sch Med, Fac Hlth Med Sci, Nedlands, WA, Australia
[9] Univ Sheffield, Bio Films & Antimicrobial Resistance Consortium OD, Sheffield, England
[10] Yamagata Prefectural Cent Hosp, Dept Infect Dis & Infect Control, Pathogen Hunters Res Collaborat Team, Yamagata, Japan
[11] Kitasato Univ, Sch Allied Hlth Sci, Grad Sch Med Sci, Dept Hlth Sci,Lab Environm Hyg, Kanagawa 2520373, Japan
[12] Naresuan Univ, Fac Sci, Dept Phys, Phitsanulok 65000, Thailand
[13] Minist Higher Educ Sci Res & Innovat, Ctr Excellence Math, Bangkok 10400, Thailand
[14] Minist Higher Educ Sci Res & Innovat, Thailand Ctr Excellence Phys, 328 Si Ayutthaya Rd, Bangkok 10400, Thailand
关键词
COVID-19; Low-and middle-income countries; Vaccine inequality; Thailand; AGE;
D O I
10.1016/j.idm.2023.11.003
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Low-and middle-income countries faced significant challenges in accessing COVID-19 vaccines during the early stages of the pandemic. In this study, we utilized an age structured modeling approach to examine the implications of various vaccination strategies, vaccine prioritization, and vaccine rollout speeds in Thailand, an upper-middle income country experiencing vaccine shortages during the early stages of the pandemic. The model directly compares the effectiveness of several vaccination strategies, including the heterologous vaccination where CoronaVac (CV) vaccine was administered as the first dose, followed by ChAdOx1 nCoV-19 (AZ) vaccine as the second dose, under varying disease transmission dynamics. We found that the traditional AZ homologous vaccination was more effective than the CV homologous vaccination, regardless of disease transmission dynamics. However, combining CV and AZ vaccines via either parallel homologous or heterologous vaccinations was more effective than relying solely on AZ homologous vaccination. Additionally, prioritizing vaccination for the elderly aged 60 years and above was the most effective way to reduce mortality when community transmission is well controlled. On the other hand, prioritizing workers aged 20-59 was most effective in lowering COVID-19 cases, irrespective of the transmission dynamics. Lastly, despite the vaccine prioritization strategy, rapid vaccine rollout speeds were crucial in reducing COVID-19 infections and deaths. These findings suggested that in low-and middle-income countries where early access to high-efficacy vaccines might be limited, obtaining any accessible vaccines as early as possible and using them in parallel with other higher efficacy vaccines might be a better strategy than waiting for and relying solely on higher-efficacy vaccines.(c) 2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. This is an open access article under the CC BY license (http:// creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:1177 / 1189
页数:13
相关论文
共 58 条
[1]  
Andrews N, 2022, NEW ENGL J MED, V386, P1532, DOI [10.1016/S1473-3099(22)00309-7, 10.1056/NEJMoa2119451]
[2]  
[Anonymous], 2020, Nature, DOI 10.1038/d41586-020-00154-w
[3]  
[Anonymous], 2021, REUTERS
[4]   Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant [J].
Bernal, Jamie Lopez ;
Andrews, Nick ;
Gower, Charlotte ;
Gallagher, Eileen ;
Simmons, Ruth ;
Thelwall, Simon ;
Stowe, Julia ;
Tessier, Elise ;
Groves, Natalie ;
Dabrera, Gavin ;
Myers, Richard ;
Campbell, Colin N. J. ;
Amirthalingam, Gayatri ;
Edmunds, Matt ;
Zambon, Maria ;
Brown, Kevin E. ;
Hopkins, Susan ;
Chand, Meera ;
Ramsay, Mary .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (07) :585-594
[5]   COVID-19 annual update: a narrative review [J].
Biancolella, Michela ;
Colona, Vito Luigi ;
Luzzatto, Lucio ;
Watt, Jessica Lee ;
Mattiuz, Giorgio ;
Conticello, Silvestro G. ;
Kaminski, Naftali ;
Mehrian-Shai, Ruty ;
Ko, Albert I. ;
Gonsalves, Gregg S. ;
Vasiliou, Vasilis ;
Novelli, Giuseppe ;
Reichardt, Juergen K. V. .
HUMAN GENOMICS, 2023, 17 (01)
[6]   Model-informed COVID-19 vaccine prioritization strategies by age and serostatus [J].
Bubar, Kate M. ;
Reinholt, Kyle ;
Kissler, Stephen M. ;
Lipsitch, Marc ;
Cobey, Sarah ;
Grad, Yonatan H. ;
Larremore, Daniel B. .
SCIENCE, 2021, 371 (6532) :916-+
[7]   Dynamic prioritization of COVID-19 vaccines when social distancing is limited for essential workers [J].
Buckner, Jack H. ;
Chowell, Gerardo ;
Springborn, Michael R. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (16)
[8]  
Chen Jiangzhuo, 2021, medRxiv, DOI 10.1101/2021.02.04.21251012
[9]   Southeast Asia is an emerging hotspot for COVID-19 [J].
Chookajorn, Thanat ;
Kochakarn, Theerarat ;
Wilasang, Chaiwat ;
Kotanan, Namfon ;
Modchang, Charin .
NATURE MEDICINE, 2021, 27 (09) :1495-1496
[10]  
Cori A., 2020, Package Epiestim